141 results about "Polyproteins" patented technology

Methods and constructs for the introduction of multiple genes into plants using a single transformation event are described. Constructs contain a single 5′ promoter operably linked to DNA encoding a modified intein splicing unit. The splicing unit is expressed as a polyprotein and consists of a first protein fused to an intein fused to a second protein. The splicing unit has been engineered to promote excision of all non-essential components in the polyprotein but prevent the ligation reactions normally associated with protein splicing. Additional genetic elements encoding inteins and additional proteins can be fused in frame to the 5′-terminus of the coding region for the second protein to form a construct for expression of more than two proteins. A single 3′ termination sequence, such as a polyadenylation sequence when the construct is to be expressed in eucaryotic cells, follows the last coding sequence. These methods and constructs are particularly useful for creating plants with stacked input traits, illustrated by glyphosate tolerant plants producing BT toxin, and / or value added products, illustrated by the production of polyhydroxyalkanoates in plants.

Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise fusion polypeptides comprising multiple Leishmania antigens, in particular, KMP11, SMT, A2 and / or CBP, or immunogenic portions or variants thereof, as well as polynucleotides encoding such fusion polypeptides.

HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfection efficiency and ability to survive subpassage greater than HCV that have wild-type polyprotein coding regions. Expression vectors comprising the above polynucleotides and HCV variants are also described, as are the provision of cells and host cells comprising the expression vectors. Methods for identifying a cell line that is permissive for infection with HCV are also provided, as are vaccines comprising the above polynucleotides in a pharmaceutically acceptable carrier. Additionally, methods for inducing immunoprotection to HCV in a primate are described, as are methods for testing a compound for inhibiting HCV replication.

The invention relates to an immunochromatographic test strip for semi-quantitatively and simultaneously detecting cTnI and Myo and a preparation method thereof. The test strip comprises a base plate, a nitrocellulose membrane, a first bonding pad, a second bonding pad, a sample pad and a water absorbing pad. According to the preparation method, the pretreated nitrocellulose membrane, first bonding pad, second bonding pad, sample pad and water absorbing pad are sequentially and mutually staggered and attached to the base plate so as to obtain the immunochromatographic test strip for simultaneously detecting the cTnI and the Myo. The immunochromatographic test strip disclosed by the invention can be used for simultaneously detecting two proteins with greater abundance difference, providing great convenience for quick diagnosis of clinical myocardial infarction and overcoming and making up the defects of low sensitiveness and narrow linear range during detection of polyprotein in a traditional immunochromatographic test strip technology. The preparation method has the advantages of simple process, low cost, simpleness and convenience in operation and favorable application prospect.

Methods and constructs for the introduction of multiple genes into plants using a single transformation event are described. Constructs contain a single 5′ promoter operably linked to DNA encoding a modified intein splicing unit. The splicing unit is expressed as a polyprotein and consists of a first protein fused to an intein fused to a second protein. The splicing unit has been engineered to promote excision of all non-essential components in the polyprotein but prevent the ligation reactions normally associated with protein splicing. Additional genetic elements encoding inteins and additional proteins can be fused in frame to the 5′-terminus of the coding region for the second protein to form a construct for expression of more than two proteins. A single 3′ termination sequence, follows the last coding sequence. These methods and constructs are particularly useful for creating plants with stacked input traits and / or value added products.

The invention belongs to great improvement of thick wine brewing technique in food field. The wine is refinedly brewed by taking natural and green glutinous millet, red grapes, mold culture, malt and the like as main materials, adding natural auxiliary material and spices and adopting modern technology. The raw materials can be selected from six kinds of grain products, fruits, flowers and plants, fermentation products, mixing agents and additives. The thick plant wine contains high nutrition, high thermal energy, multiple elements, polyprotein, polysaccharide and multiple amino acids and is a low-fat and low-proof health nourishing drink. The wine is safe and reliable when being drunk for a long time. The thick wine has faint scent and romantic charm, is sweet and clean, and is beneficial to refreshing and restoring consciousness. The thick wine has the advantages of convenient use, being clean and being easy to store and the like, and is especially suitable for middle aged people, old people, women and people who live and work in high cold regions. Being drunk for a long time, the wine is beneficial to bone and fitness strengthening, wind expelling and cold dispersing, qi and blood smoothing as well as longevity promoting, has no damage on human health, contains no melamine, Sudan red or harmful substances, and is coloured naturally. In addition, the prior art and devices are not required to be replaced in transformation of wine brewing enterprise.

Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise fusion polypeptides comprising multiple Leishmania antigens, in particular, KMP11, SMT, A2 and / or CBP, or immunogenic portions or variants thereof, as well as polynucleotides encoding such fusion polypeptides.

An immunogenic or vaccine composition to induce an immune response or protective immune response against West Nile virus (WNV) in an animal susceptible to WNV. The composition includes a pharmaceutically or veterinarily acceptable vehicle or excipient, and a vector. The vector contains heterologous nucleic acid molecule(s), expresses in vivo in the animal WNV antigen, immunogen or epitope thereof, e.g., WNV E; WNV prM and E; WNV M and E; WNV prM, WNV M and E, WNV polyprotein prM-E, WNV polyprotein M-E, or WNV polyprotein prM-M-E. The composition can contain an adjuvant, such as carbomer. Methods for making and using such a composition, including prime-boost regimes and including as to differential diagnosis, are also contemplated.

The invention relates to a method for detecting novel coronavirus 2019-nCoV through multi-protein joint inspection combination, which belongs to the technical field of novel coronavirus 2019-nCoV detection. The invention provides the method for detecting the novel coronavirus 2019-nCoV through multi-protein joint inspection combination. A detection test strip for detecting the novel coronavirus 2019-nCoV antibody is prepared by directly scribing a high-purity and specific novel coronavirus antigen on a nitrocellulose membrane, and IgG, IgM and / or IgA antibodies in a sample can be simultaneously detected by utilizing multiple antigens. Through joint inspection of three or four specific antigens, protein sequences of the antigens are optimally designed, so that the sensitivity and specificity are effectively improved, and the problems of false negative and false positive are effectively avoided.

Disclosed are useful constructs and methods for the expression of proteins using primary translation products that are processed within a recombinant host cell. Constructs comprising a single open reading frame (sORF) are described for protein expression including expression of multiple polypeptides. A primary translation product (a pro-protein or a polyprotein) contains polypeptides such as inteins or hedgehog family auto-processing domains, or variants thereof, inserted in frame between multiple protein subunits of interest. The primary product can also contain cleavage sequences such as other proteolytic cleavage or protease recognition sites, or signal peptides which contain recognition sequences for signal peptidases, separating at least two of the multiple protein subunits. The sequences of the inserted auto-processing polypeptides or cleavage sites can be manipulated to enhance the efficiency of expression of the separate multiple protein subunits. Also disclosed are independent aspects of conducting efficient expression, secretion, and / or multimeric assembly of proteins such as immunoglobulins. Where the polyprotein contains immunoglobulin heavy and light chain segments or fragments capable of antigen recognition, in an embodiment a selectable stoichiometric ratio is at least two copies of a light chain segment per heavy chain segment, with the result that the production of properly folded and assembled functional antibody is made. Modified signal peptides, including such from immunoglobulin light chains, are described.

A foot and mouth disease virus (FMDV) vaccine and method for producing same is described wherein the N terminal portion of the FMDV polyprotein, encoding the four structural proteins, 1A, 1B, 1C, and 1D, are each separated by a non-FMDV protease, preferably a cellular protease, for example, furin. The expression system may be transformed into a cell expressing the non-FMDV protease and the resulting particles recovered for use as a vaccine

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and / or preventing a disease, such as infectious bronchitis, in a subject.

An immunogenic or vaccine composition to induce an immune response or protective immune response against West Nile virus (WNV) in an animal susceptible to WNV. The composition includes a pharmaceutically or veterinarily acceptable vehicle or excipient, and a vector. The vector contains heterologous nucleic acid molecule(s), expresses in vivo in the animal WNV antigen, immunogen or epitope thereof, e.g., WNV E; WNV prM and E; WNV M and E; WNV prM, WNV M and E, WNV polyprotein prM-E, WNV polyprotein M-E, or WNV polyprotein prM-M-E. The composition can contain an adjuvant, such as carbomer. Methods for making and using such a composition, including prime-boost regimes and including as to differential diagnosis, are also contemplated.

An oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, includes a mixture of platinum complex of general formula Iwherein A each independently is an —NH3 group or an amino group containing 1 to 18 carbon atoms, B each independently is a halogen atom, a hydroxy group or a —O—C(O)—R group wherein R each independently is hydrogen atom or an alkyl, alkenyl, aryl, aralkyl, alkylamino or alkoxy group containing 1 to 10 carbon atoms or functional derivatives of these groups, and X each independently is a halogen atom or a monocarboxylate group containing 1 to 20 carbon atoms, or X together form a dicarboxylate group containing 2 to 20 carbon atoms, and at least one excipient selected from the group including a saccharide, oligosaccharide, polysaccharide, modified polysaccharide mucopolysaccharide, protein, oligoprotein, polyprotein, mucoprotein, peptide, oligopeptide and polypeptide, and optionally a lubricant and / or disintegrant, which mixture is optionally compressed into a tablet or contained in a capsule, and this tablet or capsule is optionally coated with a biodegradable layer and / or an outer pH-sensitive colonic layer, and a method of manufacturing and using the composition for treatment of colorectal carcinoma.

The invention discloses a DNA (deoxyribonucleic acid) vaccine for expressing infectious bursal disease virus polyprotein gene VP243, as well as a construction method and application thereof. A polyprotein gene (VP243) of an infectious bursal disease virus virulent strain (HLJ0504) is optimized by chicken bias codons, and cloned to a eukaryotic expression vector pCAGGS so as to construct a recombinant expression vector pCAGoptiVP243. An initially immunized 14-day SPF chick is injected with 100mu g of the prepared pCAGoptiVP243 though two points of crureus in, a 28-day chick is subjected to the secondary immunization in same dosage and way, and IBDV (infectious bursal disease virus) virulent strain (HLJ0504) strain is attacked in 14 days after secondary immunization. Results indicate that the DNA vaccine can be used for inducing antibody with higher level and providing immunized protection to the virulent strain.